COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S)
Andreas M. Nieß, Manuel Widmann, Roman Gaidai, Christian Golz, Isabel Schubert, Katty Castillo, Jan Philipp Sachs, Daniel Alexander Bizjak, Shirin Vollrath, Fritz Wimbauer, Azin Vogel, Karsten Keller, Christof Burgstahler, Anne Quermann, Arno Kerling, Gerald Schneider, Jonas Zacher, Katharina Diebold, Maximilian Grummt, C Beckendorf, Johannes Buitenhuis, F. Egger, Andreas Venhorst, Oliver Morath, Friedrich Barsch, Klaus‐Peter Mellwig, Julian Oesterschlink, Jan Wüstenfeld, Hans‐Georg Predel, Peter Deibert, Birgit Friedmann‐Bette, Frank Mayer, Anja Hirschmüller, Martin Halle, Jürgen M. Steinacker, Bernd Wolfarth, Tim Meyer, Erwin Böttinger, Marion Flechtner‐Mors, Wilhelm Bloch, Bernhard Haller, Kai Röecker, Claus Reinsberger
Abstract
Objective: It is unclear whether and to what extent COVID-19 infection poses health risks and a chronic impairment of performance in athletes. Identification of individual health risk is an important decision-making basis for managing the pandemic risk of infection with SARS-CoV-2 in sports and return to play (RTP). Methods: This study aims 1) to analyze the longitudinal rate of seroprevalence of SARS-CoV-2 in German athletes, 2) to assess health-related consequences in athletes infected with SARS-CoV-2, and 3) to reveal effects of the COVID-19 pandemic in general and of a cleared SARS-CoV-2 infection on exercise performance. CoSmo-S is a prospective observational multicenter study establishing two cohorts: 1) athletes diagnosed positive for COVID-19 (cohort 1) and 2) federal squad athletes who perform their annual sports medical preparticipation screening (cohort 2). Comprehensive diagnostics including physical examination, laboratory blood analyses and blood biobanking, resting and exercise electrocardiogram (ECG), echocardiography, spirometry and exercise testing added by questionnaires are conducted at baseline and follow-up. Results and Conclusion: We expect that the results obtained, will allow us to formulate recommendations regarding RTP on a more evidence-based level.